No profile data available.
Krebs Biochemicals & Industries Limited (KREBSBIO.NS) is a healthcare company in the drug manufacturing contractors industry, based in Visakhapatnam, India, with about 142 full-time employees.
In Q3 2026 (the quarter ended December 31, 2025) revenue was 72.74 million INR, down 36.6% from a year before. Its market capitalization was 1.21 billion INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
Krebs Biochemicals & Industries Limited engages in the manufacture of active pharmaceutical ingredients in India. It offers androstenedione for steroid intermediate indications, as well as lovastatin and simvastatin for anti-cholesterol applications.
1.21 billion INR as of October 9, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include Godavari Drugs Limited (GODAVARI.BO), Bal Pharma Limited (BALPHARMA.NS), Par Drugs and Chemicals Limited (PAR.NS), Alpa Laboratories Limited (ALPA.NS).